SEC Company Response from IMMUNIC, INC. (IMUX) (CIK 0001280776) (IMUX) — Jun 11, 2018
IMMUNIC, INC. (IMUX) (CIK 0001280776)
Date: June 11, 2018 · CIK: 0001280776 · Accession: 0001280776-18-000061
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225230
Letter
Document
June 11, 2018
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention:
Irene Paik
Erin Jaskot
Re:
Vital Therapies, Inc.
Registration Statement on Form S-3
Filed May 25, 2018
File No. 333-225230
Acceleration Request
Requested Date:
June 13, 2018
Requested Time:
4:00 PM Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Vital Therapies, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-225230) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”). The Company hereby authorizes Thomas E. Hornish of Wilson Sonsini Goodrich & Rosati, Professional Corporation, counsel for the Company, to make such request on the Company’s behalf.
The Company requests that it be notified of the effectiveness of the Registration Statement by telephone to Thomas E. Hornish of Wilson Sonsini Goodrich & Rosati, Professional Corporation at (858) 350-2392 or via email at thornish@wsgr.com. If notice of effectiveness is given by telephone, please also provide a copy of the Commission’s order declaring the Registration Statement effective to Thomas E. Hornish via facsimile at (858) 350-2399.
Securities and Exchange Commission
Re: Vital Therapies, Inc.
June 11, 2018
Page 2
Please direct any questions or comments regarding this acceleration request to Thomas E. Hornish at (858) 350-2392.
Sincerely,
Show Raw Text
CORRESP 1 filename1.htm Document June 11, 2018 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-3720 Attention: Irene Paik Erin Jaskot Re: Vital Therapies, Inc. Registration Statement on Form S-3 Filed May 25, 2018 File No. 333-225230 Acceleration Request Requested Date: June 13, 2018 Requested Time: 4:00 PM Eastern Time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Vital Therapies, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-225230) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable, or at such later time as the Company may request by telephone to the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”). The Company hereby authorizes Thomas E. Hornish of Wilson Sonsini Goodrich & Rosati, Professional Corporation, counsel for the Company, to make such request on the Company’s behalf. The Company requests that it be notified of the effectiveness of the Registration Statement by telephone to Thomas E. Hornish of Wilson Sonsini Goodrich & Rosati, Professional Corporation at (858) 350-2392 or via email at thornish@wsgr.com. If notice of effectiveness is given by telephone, please also provide a copy of the Commission’s order declaring the Registration Statement effective to Thomas E. Hornish via facsimile at (858) 350-2399. Securities and Exchange Commission Re: Vital Therapies, Inc. June 11, 2018 Page 2 Please direct any questions or comments regarding this acceleration request to Thomas E. Hornish at (858) 350-2392. Sincerely, VITAL THERAPIES, INC. By: /s/ Michael V. Swanson Michael V. Swanson Chief Financial Officer cc: Thomas E. Hornish, Esq. Wilson Sonsini Goodrich & Rosati, Professional Corporation